| 11/16/2026 8:01 AM | Mymd Pharmaceuticals (1321834) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/13/2026 4:00 PM | Mymd Pharmaceuticals (1321834) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/02/2026 4:00 PM | Mymd Pharmaceuticals (1321834) Issuer Silverman Joshua (1524858) Reporting | Form 4/A | |
| 10/02/2026 4:02 PM | Mymd Pharmaceuticals (1321834) Issuer Silverman Joshua (1524858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 4:07 PM | Ehrlichman Yossef (2155536) Reporting Mymd Pharmaceuticals (1321834) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 09/18/2026 4:16 PM | Mymd Pharmaceuticals (1321834) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2026 3:30 PM | Mymd Pharmaceuticals (1321834) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/17/2026 8:34 PM | Fagan Charles Todd (2150127) Reporting Mymd Pharmaceuticals (1321834) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/02/2026 4:00 PM | Mymd Pharmaceuticals (1321834) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2026 4:33 PM | Mymd Pharmaceuticals (1321834) Issuer Voss Chelsea Sierra (2108237) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/29/2026 4:19 PM | Mymd Pharmaceuticals (1321834) Filer | Form 10-K/A | |
Get the Latest News and Ratings for QCLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mymd Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/15/2026 5:29 PM | Mymd Pharmaceuticals (1321834) Issuer Silverman Joshua (1524858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:29 PM | Bernstein Bruce (1665472) Reporting Mymd Pharmaceuticals (1321834) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:29 PM | Mymd Pharmaceuticals (1321834) Issuer White Billy Joe (1546805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:29 PM | Glass Mitchell (2023649) Reporting Mymd Pharmaceuticals (1321834) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:29 PM | Friscia Stephen (2028845) Reporting Mymd Pharmaceuticals (1321834) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:29 PM | Mymd Pharmaceuticals (1321834) Issuer Voss Chelsea Sierra (2108237) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 4:20 PM | Mymd Pharmaceuticals (1321834) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/31/2026 3:30 PM | Mymd Pharmaceuticals (1321834) Filer | Form NT 10-K | |
| 03/13/2026 3:30 PM | Mymd Pharmaceuticals (1321834) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 11:15 PM | Mymd Pharmaceuticals (1321834) Filer | Form EFFECT | |
| 02/11/2026 4:17 PM | Mymd Pharmaceuticals (1321834) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 01/30/2026 4:30 PM | Mymd Pharmaceuticals (1321834) Issuer Voss Chelsea Sierra (2108237) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/30/2026 4:31 PM | Mymd Pharmaceuticals (1321834) Issuer Voss Chelsea Sierra (2108237) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 4:00 PM | Mymd Pharmaceuticals (1321834) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/09/2025 8:25 AM | Mymd Pharmaceuticals (1321834) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/01/2025 4:21 PM | Mymd Pharmaceuticals (1321834) Filer | Form 424B3 | |
| 11/30/2025 11:15 PM | Mymd Pharmaceuticals (1321834) Filer | Form EFFECT | |
| 11/19/2025 4:13 PM | Mymd Pharmaceuticals (1321834) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |